Literature DB >> 29163711

Identification of a protein associated with the activity of cytokine-induced killer cells.

Jingsong Cao1,2, Cong Chen3, Yongqiang Gao1,2, Li Hu1,2, Yu Liang1,2, Jianhua Xiao1,2.   

Abstract

Cytokine-induced killer cells (CIKs) adoptive immunotherapy for efficient antitumor ability is used clinically, but details regarding the proteins associated with CIK activity remain unclear. In the current study, the cytotoxicity of CIKs on hepatoma was identified to be significantly downregulated by 1.61-fold following gentamincin treatment. Further research revealed that a differentially expressed protein (P43) was significantly downregulated by 1.22-fold using one-dimensional gel electrophoresis analysis. Of these, the P43 was identified as human haptoglobin using liquid chromatography-mass spectrometry. Western blotting demonstrated that the haptoglobin specifically reacted with rabbit anti-human-haptoglobin. Furthermore, western blotting results verified that the haptoglobin was significantly downregulated by 1.17-fold compared with the control group. In addition, the expression of haptoglobin mRNA was significantly downregulated by 1.73-fold following gentamincin treatment. Taken together, the results of the present study demonstrated that the expression of haptoglobin protein was associated with the activity of CIKs, and the results will be beneficial to the further investigation of CIK activity-enhancement mechanism.

Entities:  

Keywords:  activity-enhancing mechanism; cytokine-induced killer cells; haptoglobin; liquid chromatography-mass spectrometry; related activity protein

Year:  2017        PMID: 29163711      PMCID: PMC5691391          DOI: 10.3892/ol.2017.7042

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  37 in total

1.  Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo.

Authors:  Jianhua Huang; Chonghui Li; Yao Wang; Haiyan Lv; Yelei Guo; Hanren Dai; Max S Wicha; Alfred E Chang; Qiao Li
Journal:  Clin Immunol       Date:  2013-08-07       Impact factor: 3.969

2.  Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.

Authors:  Ke Pan; Xun-Xing Guan; Yong-Qiang Li; Jing-Jing Zhao; Jian-Jun Li; Hui-Juan Qiu; De-Sheng Weng; Qi-Jing Wang; Qing Liu; Li-Xi Huang; Jia He; Shi-Ping Chen; Miao-La Ke; Yi-Xin Zeng; Jian-Chuan Xia
Journal:  Clin Cancer Res       Date:  2014-03-25       Impact factor: 12.531

3.  Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.

Authors:  Rabea Asleh; John Ward; Nina S Levy; Shady Safuri; Doron Aronson; Andrew P Levy
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

4.  Isoforms of wild type proteins often appear as low molecular weight bands on SDS-PAGE.

Authors:  Ju Zhang; Xiaomin Lou; Haihong Shen; Lucas Zellmer; Yuan Sun; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Biotechnol J       Date:  2014-07-04       Impact factor: 4.677

5.  Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features.

Authors:  Loretta Gammaitoni; Lidia Giraudo; Valeria Leuci; Maja Todorovic; Giulia Mesiano; Franco Picciotto; Alberto Pisacane; Alessandro Zaccagna; Maria Giuseppa Volpe; Susanna Gallo; Daniela Caravelli; Elena Giacone; Tiziana Venesio; Antonella Balsamo; Ymera Pignochino; Giovanni Grignani; Fabrizio Carnevale-Schianca; Massimo Aglietta; Dario Sangiolo
Journal:  Clin Cancer Res       Date:  2013-06-21       Impact factor: 12.531

6.  The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.

Authors:  Eva Rettinger; Selim Kuçi; Ivonne Naumann; Petra Becker; Hermann Kreyenberg; Martina Anzaghe; Andre Willasch; Ulrike Koehl; Gesine Bug; Martin Ruthardt; Thomas Klingebiel; Simone Fulda; Peter Bader
Journal:  Cytotherapy       Date:  2011-10-06       Impact factor: 5.414

7.  Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.

Authors:  Tessa Gargett; Michael P Brown
Journal:  Cytotherapy       Date:  2015-01-06       Impact factor: 5.414

8.  Development of monoclonal antibodies to pre-haptoglobin 2 and their use in an enzyme-linked immunosorbent assay (ELISA).

Authors:  J J Flanagan; A Arjomandi; M L Delanoy; E Du Paty; P Galea; D Laune; F Rieunier; R P Walker; S R Binder
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

9.  The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with K-ras mutant peptide.

Authors:  Guang Tan; Xin Zhang; Hongbo Feng; Haifeng Luo; Zhongyu Wang
Journal:  Clin Dev Immunol       Date:  2011-10-19

10.  Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer.

Authors:  Klaus Felix; Oliver Hauck; Stefan Fritz; Ulf Hinz; Martina Schnölzer; Tore Kempf; Uwe Warnken; Angelika Michel; Michael Pawlita; Jens Werner
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more
  1 in total

1.  Identification of an activation-related protein in B cells in the ABO incompatible condition.

Authors:  Jingsong Cao; Cong Chen; Luogen Liu; Yunsheng Zhang; Hong Zhou; Jianhua Xiao; Yi Wang
Journal:  Exp Ther Med       Date:  2019-11-22       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.